Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with no effective treatments or known biomarkers for definitive diagnosis, substantiating the need for early detection of AD and early intervention. This project employs Magnetic Resonance Spectroscopy (MRS) to measure changes in neurometabolites as compared to behavioural measures of cognitive function, in a transgenic rat model of AD under treatment conditions. Preliminary results suggest that changes in metabolite levels are present before the onset of cognitive impairment, and between treatment and control groups, with some of these changes being sexually dimorphic.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords